Literature DB >> 7686370

Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis.

D Veale1, G Yanni, S Rogers, L Barnes, B Bresnihan, O Fitzgerald.   

Abstract

OBJECTIVE: To define the immunohistologic features of the synovial membrane (SM) of patients with psoriatic arthritis (PA) and to compare them with those of an age- and disease-duration-matched population of patients with rheumatoid arthritis (RA).
METHODS: Synovial membrane needle biopsy was performed on 15 PA patients with knee involvement (8 had asymmetric oligoarthritis and 7 had symmetric polyarthritis) and on 15 RA controls. Specimens were stained with monoclonal antibodies against T cells (CD3, CD8, CD4, CD45RO), B cells (CD20), macrophages (Mac387, CD14), and cells bearing class II antigens (DAKO-DR). Vascular endothelium was examined using a polyclonal antibody to Factor VIII-related antigen, and adhesion molecule expression was examined using antibodies 1.3B6, 6.5B5, and 1.4C3, which identify endothelial leukocyte adhesion molecule 1 (ELAM-1), intercellular adhesion molecule 1 (ICAM-1), and vascular cell adhesion molecule 1 (VCAM-1), respectively.
RESULTS: There was significantly less lining layer hyperplasia, fewer macrophages, and a greater number of blood vessels in PA SM than in RA SM: ELAM-1 expression was less intense in PA than in RA SM, while there was no difference in expression of ICAM-1 and VCAM-1. Numbers of B cells, T cells, and T cell subsets (predominantly CD4, CD45RO T cells) were similar in both groups of patients.
CONCLUSION: Our findings demonstrate important differences in the immunohistologic features of PA and RA SM: The PA SM is more vascular, ELAM-1 expression is less intense, and fewer macrophages invade the stroma and migrate to the lining layer than in RA SM: However, the lymphocytic infiltrate in the SM of both groups is similar.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686370     DOI: 10.1002/art.1780360705

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  66 in total

1.  TNFalpha therapy in psoriatic arthritis and psoriasis.

Authors:  P Mease
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

2.  Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy.

Authors:  E Kruithof; D Baeten; F Van den Bosch; H Mielants; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2004-09-23       Impact factor: 19.103

Review 3.  Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases?

Authors:  D D Gladman
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

4.  Ectopic lymphoid neogenesis in psoriatic arthritis.

Authors:  Juan D Cañete; Begoña Santiago; Tineke Cantaert; Raimon Sanmartí; Antonio Palacin; Raquel Celis; Eduard Graell; Beatriz Gil-Torregrosa; Dominique Baeten; José L Pablos
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

5.  Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.

Authors:  A W R van Kuijk; P Reinders-Blankert; T J M Smeets; B A C Dijkmans; P P Tak
Journal:  Ann Rheum Dis       Date:  2006-05-25       Impact factor: 19.103

6.  Expansion of a unique macrophage subset in rheumatoid arthritis synovial lining layer.

Authors:  M Tanaka; T Nagai; Y Tsuneyoshi; N Sunahara; T Matsuda; T Nakamura; S Tsuyama; K Hasui; O FitzGerald; T Matsuyama
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

Review 7.  Targeting IL-17 in psoriatic arthritis.

Authors:  Elizabeth A Wang; Erika Suzuki; Emanual Maverakis; Iannis E Adamopoulos
Journal:  Eur J Rheumatol       Date:  2017-11-10

8.  Adhesion molecule expression and complement activation in vessel walls in synovial tissue from patients with chronic inflammatory joint disease.

Authors:  O J Mellbye; Y Shen; K Høgåsen; T E Mollnes; O Førre
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

Review 9.  MRI in psoriatic arthritis: insights into pathogenesis and treatment response.

Authors:  Fiona M McQueen; Nicola Dalbeth; Anthony Doyle
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

Review 10.  Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective.

Authors:  David Kane; Oliver FitzGerald
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.